Aug 16, 2021 9:10am EDT CollPlant Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing Webinar
Jun 22, 2021 7:30am EDT 3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments
Jun 04, 2021 7:00am EDT CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs
May 27, 2021 7:00am EDT CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million
May 25, 2021 9:00am EDT CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs
Mar 29, 2021 7:00am EDT CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors
Mar 26, 2021 9:00am EDT CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020
Feb 25, 2021 9:20am EST Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants